Pages that link to "Q24337048"

The following pages link to Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin (Q24337048):

Displaying 37 items.

• Heparin binding EGF like growth factor (Q14914534) (← links)
• Latent transforming growth factor beta-binding protein-3 and fibulin-1C interact with the extracellular domain of the heparin-binding EGF-like growth factor precursor (Q21284179) (← links)
• The metalloendopeptidase nardilysin (NRDc) is potently inhibited by heparin-binding epidermal growth factor-like growth factor (HB-EGF) (Q24534617) (← links)
• N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration (Q24535534) (← links)
• CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor (Q24651739) (← links)
• Heparin binding-epidermal growth factor-like growth factor for the regeneration of chronic tympanic membrane perforations in mice (Q27306884) (← links)
• Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity (Q28631171) (← links)
• The heparin-binding domain of HB-EGF mediates localization to sites of cell-cell contact and prevents HB-EGF proteolytic release. (Q33917661) (← links)
• Corneal wound healing, a newly identified function of CAP37, is mediated by protein kinase C delta (PKCδ). (Q34020741) (← links)
• Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques (Q34196344) (← links)
• Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate (Q34367377) (← links)
• Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity (Q34450568) (← links)
• Structural requirements for the tissue-specific and tissue-general functions of the Caenorhabditis elegans epidermal growth factor LIN-3. (Q34608024) (← links)
• Brief treatment with heparin-binding EGF-like growth factor, but not with EGF, is sufficient to accelerate epithelial wound healing (Q35127095) (← links)
• Heparin-binding EGF-like growth factor is up-regulated in the obstructed kidney in a cell- and region-specific manner and acts to inhibit apoptosis (Q35809892) (← links)
• The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor (Q36235363) (← links)
• Removal of the membrane-anchoring domain of epidermal growth factor leads to intracrine signaling and disruption of mammary epithelial cell organization (Q36256364) (← links)
• Highly efficient delivery of functional cargoes by the synergistic effect of GAG binding motifs and cell-penetrating peptides. (Q36498334) (← links)
• The significance of disulfide bonding in biological activity of HB-EGF, a mutagenesis approach (Q37077461) (← links)
• Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis (Q37265743) (← links)
• Intestinal phenotype in mice overexpressing a heparin-binding EGF-like growth factor transgene in enterocytes (Q37289601) (← links)
• Engineering insulin-like growth factor-1 for local delivery (Q37368900) (← links)
• Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use. (Q38418286) (← links)
• Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries (Q38528036) (← links)
• Receptor-based antidote for diphtheria. (Q39654768) (← links)
• Involvement of wound-associated factors in rat brain astrocyte migratory response to axonal injury: in vitro simulation (Q39759229) (← links)
• Amino-terminal deletion of heparin-binding epidermal growth factor-like growth factor4-127 stimulates cell proliferation but lacks insulin-like activity (Q40138606) (← links)
• Syndecan family of cell surface proteoglycans: developmentally regulated receptors for extracellular effector molecules (Q40412665) (← links)
• Identification of betacellulin as a major peptide growth factor in milk: purification, characterization and molecular cloning of bovine betacellulin (Q40913502) (← links)
• Role of membrane-anchored heparin-binding epidermal growth factor-like growth factor and CD9 on macrophages (Q41067946) (← links)
• Gene expression profiling of TGFbeta2- and/or BMP7-treated trabecular meshwork cells: Identification of Smad7 as a critical inhibitor of TGF-beta2 signaling. (Q41595360) (← links)
• Interaction of heparin with synthetic peptides corresponding to the C-terminal domain of intestinal mucins (Q42522511) (← links)
• 13C-NMR relation study of heparin-disaccharide interactions with tripeptides GRG and GKG. (Q42981760) (← links)
• The Modified Heparin-Binding L-Asparaginase of Wolinella succinogenes. (Q54245410) (← links)
• Heparin-binding epidermal growth factor-like growth factor: p91 activation induction of plasminogen activator/inhibitor, and tubular morphogenesis in human microvascular endothelial cells. (Q54526368) (← links)
• Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα (Q61805838) (← links)
• Role of Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Oxidative Stress-Associated Metabolic Diseases (Q89799077) (← links)